** Shares of telehealth firm Doximity DOCS.N slump 14.7% to $49.84 after co's forecast misses expectations
** Co forecasts FY26 revenue between $619 mln and $631 mln vs analysts' estimate of $635 mln - data compiled by LSEG
** Midpoint of Q1 revenue outlook also below estimate
** At least four brokerages cut PT, including Truist Securities
** Piper Sandler lowers PT but says they "would buy this morning's weakness" as co's top-line growth forecast is appropriate due to uncertain impact of policy
** Eight out of 20 analysts rate stock as "buy" or higher, 12 "hold"; median PT is $70
** Including session's moves, DOCS down 5.6% YTD
(Reporting by Twesha Dikshit)
((Twesha.Dikshit@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。